Common Contracts
6 similar Underwriting Agreement contracts by Acorda Therapeutics Inc, Bottomline Technologies Inc /De/, Chart Industries Inc, others
CLOVIS ONCOLOGY, INC. Underwriting AgreementUnderwriting Agreement • April 19th, 2018 • Clovis Oncology, Inc. • Pharmaceutical preparations • New York
Standard Contracts
TIMKENSTEEL CORPORATION Underwriting AgreementUnderwriting Agreement • May 31st, 2016 • TimkenSteel Corp • Steel works, blast furnaces & rolling mills (coke ovens) • New York
TimkenSteel Corporation, an Ohio corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), $75,000,000 principal amount of its 6.00% Convertible Senior Notes due 2021 (the “Underwritten Securities”) and, at the option of the Underwriters, up to an additional $11,250,000 principal amount of its 6.00% Convertible Senior Notes due 2021 (the “Option Securities”) if and to the extent that the Underwriters shall have determined to exercise the option to purchase such 6.00% Convertible Senior Notes due 2021 granted to the Underwriters in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into cash, common shares (the “Underlying Securities”) of the Company, without par value (the “Common Shares”), or a combination thereof, at the Company’s election, subje
ACORDA THERAPEUTICS, INC.Underwriting Agreement • June 23rd, 2014 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Acorda Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to you (the “Underwriter”) $300,000,000 principal amount of its 1.75% Convertible Notes due 2021 (the “Underwritten Securities”) and, at the option of the Underwriter, up to an additional $45,000,000 principal amount of its 1.75% Convertible Notes due 2021 (the “Option Securities”) if and to the extent that the Underwriter shall have determined to exercise the option to purchase such 1.75% Convertible Notes due 2021 granted to the Underwriter in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities.” The Securities will be convertible into cash, shares of common stock of the Company, par value $0.001 per share (the “Common Stock”), or a combination of cash and shares of Common Stock (any shares of Common Stock issuable upon conversion of the Securities, including, for the avoidance of doubt, any additional shares deliverable upon conv
BOTTOMLINE TECHNOLOGIES (de), INC.Underwriting Agreement • December 13th, 2012 • Bottomline Technologies Inc /De/ • Services-prepackaged software • New York
Bottomline Technologies (de), Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), $165,000,000 principal amount of its 1.50% Convertible Senior Notes due 2017 (the “Underwritten Securities”) and, at the option of the Underwriters, up to an additional $24,750,000 principal amount of its 1.50% Convertible Senior Notes due 2017 (the “Option Securities”) if and to the extent that the Underwriters shall have determined to exercise the option to purchase such 1.50% Convertible Senior Notes due 2017 granted to the Underwriters in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into cash up to the aggregate principal amount of the Securities being converted and shares (the “Underlying Securities”) of common stock of the Company, p
CHART INDUSTRIES, INC. Convertible Senior Subordinated Notes due 2018 UNDERWRITING AGREEMENTUnderwriting Agreement • August 3rd, 2011 • Chart Industries Inc • Fabricated plate work (boiler shops) • New York
Chart Industries, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), $250,000,000 principal amount of its 2% Convertible Senior Subordinated Notes due 2018 (the “Underwritten Securities”) and, at the option of the Underwriters, up to an additional $37,500,000 principal amount of its 2% Convertible Senior Subordinated Notes due 2018 (the “Option Securities”) if and to the extent that the Underwriters shall have determined to exercise the option to purchase such 2% Convertible Senior Subordinated Notes due 2018 granted to the Underwriters in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities.” The Securities will be convertible into shares (the “Underlying Securities”) of common stock of the Company, par value $0.01 per share (the “Common Stock”). The Securitie
VOLCANO CORPORATION Underwriting AgreementUnderwriting Agreement • September 15th, 2010 • Volcano Corp • Electromedical & electrotherapeutic apparatus • New York
Volcano Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to J.P. Morgan Securities LLC and each of the other underwriters, if any, named on Schedule 1 hereto (each an “Underwriter” and collectively, the “Underwriters”), for whom J.P. Morgan Securities LLC is acting as representative (the “Representative”), $100,000,000 principal amount of its 2.875% Convertible Senior Notes due 2015 (the “Underwritten Securities”) and, at the option of the Underwriters, up to an additional $15,000,000 principal amount of its 2.875% Convertible Senior Notes due 2015 (the “Option Securities”) if and to the extent that the Underwriters shall have determined to exercise the option to purchase such 2.875% Convertible Senior Notes due 2015 granted to the Underwriters in Section 2 hereof. The Underwritten Securities and, if and to the extent issued, the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into shares (the “Underlying S
